Efficiency of 5 fluorouracil solution application using dermaroller in the treatment of vitiligo
##plugins.themes.academic_pro.article.main##
Abstract
Introduction: Vitiligo is a common acquired condition, resulting from the progressive loss of melanocytes (1). Vitiligo affects 0.5–1 % of the world’s population, It can appear at any age. The prevalence is probably the same in sexes, but higher prevalence is suggested in dark-skinned individuals (1,2). Vitiligo Is a major dermatologic challenge considering the many available therapeutic modalities (5). Case report: We present two patients who were treated with 5FU and microneedling using a dermaroller over a period of 3 months. Both patients are in their 3rd decade of life, diagnosed with vitiligo several years ago. The treated lesions were stable and unchanged over time. We present the results of the treatment together with the pathohistological finding of treated and untreated lesions. Conclusion: After needling and application of topical 5-fluorouracil, patohistology report shows a strong inflammatory reaction and minor edema. New promising therapeutic modalitie is topical 5-fluorouracil (5-FU), which probably stimulates repigmentation in vitiligo by direct over stimulation of proliferation of the melanocytes and an increase in the number of melanosomes in the keratinocytes.
Keywords: Microneedling, 5-fluorouracil, repigmentation, vitiligo
##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
-
1. Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet 2015; 386:74.
2. Mohammed GF, Gomaa AH, Al-Dhubaibi MS. Highlights in pathogenesis of vitiligo. World J Clin Cases 2015; 3:221.
3. Krüger C, Schallreuter KU. Stigmatisation, Avoidance Behaviour and Difficulties in Coping are Common Among Adult Patients with Vitiligo. Acta Derm Venereol 2015; 95:553.
4. Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol 2014; 31:309.
5. Bacigalupi RM, Postolova AM, Davis RS. Evidence -based, non-surgical treatments for vitiligo: a review. Am J Clin Dermatol. 2012;13(4):217–237.
6. Savant SS. Surgical therapy of vitiligo: current status. Ind J Dermatol Venereol Leprol. 2005; 71:307-10.
7. Gauthier Y, Anbar T, Lepreux S, et al. Possible mechanisms by which topical 5-fluorouracil and dermabrasion could induce pigment spread in vitiligo skin: an experimental study. ISRN Dermatol. 2013;8:49–52.
8. T. Tsuji and T. Hamada, “Topically administered fluorouracil in vitiligo,” Archives of Dermatology, vol. 119, no. 9, pp. 722–727, 1983.
9. Kumar А, Bharti R, Agarwal S. Microneedling with Dermaroller 192 needles along with 5-fluorouracil solution in the treatment of stable vitiligo. J Am Acad Dermatol. 2019 Sep;81(3):e67-e69
10. Santosh SK, Sushantika, Mohan L, Gupta AK, Mohammad A, Kumar N. Treatment of Vitiligo with 5-Fluorouracil after Microneedling of the lesion. Int J Sci Stud 2018;5(11):125-127.
11. Shashikiran AR, Gandhi S, Murugesh SB, Kusagur M, Sugareddy. Efficacy of topical 5% fluorouracil needling in vitiligo. Indian J Dermatol Venereol Leprol 2018;84:203-5.